H1N1 flu is caused by the H1N1 strain of influenza virus. Family: Orthomyxovirus. Major outbreaks of H1N1 strains in human include the Spanish Flu (1977) and the 2009 swine flu pandemic. The virus contains the glycoproteins- Hemagglutinin and neuraminidase. For this reason they’re described as H1N1, H2N2 etc.
SYMPTOMS:
- Fever
- Chills and cough
- Sore throat
- Runny nose
- Watery red eyes
- Body ache
- Headache
- Diarrhoea
- Nausea and Vomiting
EMERGENCY SYMPTOMS: If they are present consult the General Physician as soon as possible.
- Difficulty in breathing
- Chest pain
- Giddiness
- Seizures
TRANSMISSION: Airborne spread (oropharynx, nasopharynx). Influenza virus infects the cells that line your nose, throat, and lungs
COMPLICATIONS:
- Pneumonia
- Respiratory Failure
- Confusion
- Seizures
DIAGNOSIS:
MOLECULAR TESTS: These may include conventional reverse transcriptase PCR, office based rapid molecular testing, and multiplex molecular platforms that can detect influenza in addition to several other common respiratory pathogens. RT-PCR yields the best performance based on sensitivity and specificity data.
RAPID ANTIGEN OR ANTIBODY IMMUNOASSAYS: Although these are available, most choose molecular testing over these immunoassays owing to their low sensitivity.
VIRAL CULTURE: Although viral culture is available, it is not very useful in clinical practice.
Serology: Serologic testing is not recommended for diagnosis because paired sera ( acute and convalescent) are required, thereby limiting the timelines of these tests in patient care. They may be more useful in epidemiologic studies.
PREVENTION:
- Wash your hands thoroughly and frequently. Soap and water is beneficial. If not available use alcohol based sanitizers.
- Cover your coughs and sneeze with a tissue or your elbow or hands, then wash your hands immediately
- Avoid touching your face,eyes,nose
- Clean the surfaces which are regularly being touched eg. Door handle.
TREATMENT:
SUPPORTIVE CARE:
- Drink more fluids and stay hydrated.
- NSAID’S for pain relief
- Antivirals which include Oseltamivir, Zanamivir, Peramivir
VACCINE:
The 2009 influenza A (H1N1) monovalent vaccine was released in mid-October. The immunization series consisted of 2 doses for children younger than 10 years consisting of an initial dose and a booster to be administered several weeks later. Adults and children 10 years and older received a single dose. Targeted populations recommended to receive the 2009 H1N1 vaccine included pregnant women, household contacts and caregivers of children younger than 6 months, healthcare and emergency medical personnel, children aged 6 months to 18 years, young adults aged 19-24 years, and persons aged 25-64 years with conditions associated with higher risk of medical complications
ROUTE OF ADMINISTRATION: 0.5ml intramuscularly in the deltoid muscle of upper arm.